πŸ‡ΊπŸ‡Έ FDA
Patent

US 8492345

Cyclic peptide antitumor agents

granted A61KA61K38/12A61P

Quick answer

US patent 8492345 (Cyclic peptide antitumor agents) held by Northwestern University expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/12, A61P, A61P35/00